Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Six-year FIX-padua gene therapy in hemophilia B.

Blood advances·2026
Same author

Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transfer.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

CD4<sup>+</sup> T cell protection against murine Salmonella infection is female-specific and estrogen-dependent.

Nature communications·2026
Same author

Factor VIII originates primarily from anatomically distinct subsets of liver sinusoidal endothelial cells.

Blood advances·2026
Same author

Early Life Food Desert Status Is Associated With Alpha and Gamma-Tocopherol Levels and Infant Lung Function.

Pediatric pulmonology·2026
Same author

Engineering Marker-Free Lettuce Chloroplast Genome to Express Functional Glucagon-Like Peptide-1 Receptor Agonists Exenatide and Lixisenatide.

Plant biotechnology journal·2026

相关实验视频

Updated: Jun 18, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.4K

针对花生过敏的基于病毒载体的免疫疗法

Miguel Gonzalez-Visiedo1, Roland W Herzog1, Maite Munoz-Melero1

  • 1Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Viruses
|July 27, 2024
PubMed
概括

使用腺相关病毒 (AAV) 载体的基因疗法在治疗食物过敏 (FA) 方面表现有前途. 这种方法诱导调节性T细胞 (Tregs) 并防止过敏反应,为FA管理提供了潜在的新途径.

关键词:
腺相关病毒的病毒.食物过敏 食物过敏免疫耐受性 免疫耐受性肝脏的基因转移是肝脏的基因转移对于花生过敏的过敏

更多相关视频

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.1K

相关实验视频

Last Updated: Jun 18, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.4K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.1K

科学领域:

  • 免疫学 免疫学 免疫学
  • 基因治疗 基因治疗
  • 过敏研究 研究过敏

背景情况:

  • 食物过敏 (FA) 影响高达10%的人口,源于免疫系统无法容忍饮食抗原的失败.
  • 花生过敏是一种常见的FA,具有像过敏反应等严重反应的高风险.
  • 目前的免疫疗法可能无法提供持久的保护,这凸显了对新疗法的需求.

研究的目的:

  • 研究使用腺相关病毒 (AAV) 载体治疗食物过敏的肝脏导向基因疗法的疗效.
  • 为了确定AAV介导的基因疗法是否可以诱导抗原特异性调节T细胞 (Tregs) 并预防过敏反应.

主要方法:

  • 在食物过敏的小鼠模型中利用腺相关病毒 (AAV) 载体进行肝脏导向的基因疗法.
  • 施用了表达花生抗原 (Ara h1,Ara h2,Ara h3,Ara h6) 或单个抗原 (Ara h3) 的AAV载体.
  • 评估了转基因产品特异性Tregs的诱导,致病原体抗体的根除以及对过敏反应的保护.

主要成果:

  • 在FA模型中,AAV基因疗法成功诱导了抗原特异性Tregs,并消除了先前存在的致病性抗体.
  • 四个花生抗原或单个Ara h3表达的肝脏联合表达,在一个皮皮类模型中阻止了花生过敏的发展.
  • 该方法在卵胺诱导的FA模型中证明了对过敏反应的保护.

结论:

  • 以肝脏为导向的AAV基因疗法是诱导食物过敏患者免疫耐受性的有希望的策略.
  • 这种方法可以解决在FA患者中观察到的Treg数量和/或功能的减少.
  • AAV基因疗法为管理食物过敏提供了潜在的治疗途径,包括花生过敏.